CNS Pharmaceuticals, Inc. Share Price
NASDAQ: CNSP | Micro CapCNS Pharmaceuticals, Inc. Stock Performance
CNS Pharmaceuticals, Inc. Share Price Today
As of 29 October 2026, CNS Pharmaceuticals, Inc.'s share price is $4.62. The stock opened at $4.88, compared to its previous close of $5.35. During today's trading session, CNS Pharmaceuticals, Inc.'s share price traded between $4.88 and $4.88, with an average price of $4.88. Over the past 52 weeks, the stock has recorded a high of $10.41 and a low of $1.91. In terms of performance, CNS Pharmaceuticals, Inc.'s share price has risen by 110.00% over the last six months and is down 44.34% on a year-on-year basis.
CNS Pharmaceuticals, Inc. Share Price Chart
CNS Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
CNS Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
CNS Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $5.45 | $4.88 | -17.71% |
Sep 2026 | $5.80 | $5.93 | +8.81% |
Aug 2026 | $5.45 | $5.45 | -6.03% |
Jul 2026 | $4.88 | $5.80 | +37.44% |
Jun 2026 | $5.11 | $4.22 | -16.27% |
May 2026 | $9.17 | $5.04 | +129.09% |
Apr 2026 | $2.27 | $2.20 | -4.76% |
Mar 2026 | $3.13 | $2.31 | -26.67% |
Feb 2026 | $5.38 | $3.15 | -44.25% |
Jan 2026 | $5.62 | $5.65 | +8.03% |
Dec 2025 | $6.81 | $5.23 | -25.29% |
Nov 2025 | $7.17 | $7.00 | -15.66% |